Hyun Dong Yoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hyun Dong Yoo has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Seong Min Kim
Department of Neurosurgery and Neurology, Eulji University Hospital, College of Medicine, Eulji University, Daejeon 35233, Republic of Korea
4 shared publications - Seung Young Chung
Eulji University Hospital, Eulji University College of Medicine
4 shared publications - Ki Seok Park
Department of Neurosurgery and Neurology, Eulji University Hospital, College of Medicine, Eulji University, Daejeon 35233, Republic of Korea
3 shared publications - Seungjun Ryu
Department of Neurosurgery, School of Medicine, Eulji University, Daejeon 34824, Republic of Korea
3 shared publications Jae Guk Kim
Eulji University Hospital, Eulji University College of Medicine
2 shared publications- Jae Guk Kim
Department of Neurosurgery and Neurology, Eulji University Hospital, College of Medicine, Eulji University, Daejeon 35233, Republic of Korea
2 shared publications
Latest Publications
- 10 November 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1)
After ENRICH: Evidence boundaries and unresolved questions for early minimally invasive evacuation in lobar intracerebral hemorrhage
- 10 November 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1)
After ENRICH: Evidence boundaries and unresolved questions for early minimally invasive evacuation in lobar intracerebral hemorrhage
- Open Access
- 6 October 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1844523
Post-traumatic cognitive decline and neurodegenerative disease: a narrative review and proposed framework for etiologic assessment
Background: When a patient with a history of traumatic brain injury (TBI) develops progressive cognitive decline months to years after injury, clinicians must consider injury sequelae, an independent neurodegenerative disease, or both. Existing diagnostic frameworks each address a different aspect of this question, and none was constructed to apportion contribution between them. The distinction matters for management because AD-directed therapy should be considered only after biological Alzheimer’s disease (AD) has been established, followed by separate assessment of treatment eligibility and safety. Objective: To synthesise evidence on cognitive change after TBI and the clinical, biomarker, and neuroimaging information available when delayed decline is evaluated, and to propose a structure for that evaluation. Methods: Structured narrative review. A documented de novo PubMed search was conducted on 27 July 2026, covering January 2015 to the search date, using two complementary strategies: one addressing cognitive, functional and neurodegenerative outcomes after TBI, and one addressing biomarker and neuroimaging evidence with longitudinal and prognostic terms. Diagnostic and research criteria, neuropathological and mechanistic references, comparator biomarker studies, and treatment trials were identified through targeted retrieval and reference checking. Exhaustive title and abstract screening, dual-reviewer study selection, formal risk-of-bias assessment, and quantitative synthesis were not undertaken. Results: Four patterns of cognitive change after TBI are proposed as unvalidated longitudinal clinical heuristics rather than validated diagnostic categories, and no prevalence is estimated for any of them. Delayed progressive deterioration following an initial plateau presents the greatest diagnostic difficulty. Blood biomarkers can support evaluation for coexisting biological AD, but neurofilament light and glial fibrillary acidic protein kinetics vary with injury severity and sampling window, and no validated biomarker profile identifies injury-driven neurodegeneration in an individual patient. Tau-related pathology, impaired protein clearance, and chronic neuroinflammatory activity are plausible contributors not shown to form a unified causal cascade. Conclusion: Current evidence supports structured longitudinal reassessment and evaluation of competing explanations rather than etiological classification by biomarker pattern. A proposed assessment pathway, and a framework for stating what can and cannot be concluded in an individual patient, are offered as testable structures, including for medicolegal settings in which causal attribution is requested.
- 6 October 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1844523
Open AccessPost-traumatic cognitive decline and neurodegenerative disease: a narrative review and proposed framework for etiologic assessment
Background: When a patient with a history of traumatic brain injury (TBI) develops progressive cognitive decline months to years after injury, clinicians must consider injury sequelae, an independent neurodegenerative disease, or both. Existing diagnostic frameworks each address a different aspect of this question, and none was constructed to apportion contribution between them. The distinction matters for management because AD-directed therapy should be considered only after biological Alzheimer’s disease (AD) has been established, followed by separate assessment of treatment eligibility and safety. Objective: To synthesise evidence on cognitive change after TBI and the clinical, biomarker, and neuroimaging information available when delayed decline is evaluated, and to propose a structure for that evaluation. Methods: Structured narrative review. A documented de novo PubMed search was conducted on 27 July 2026, covering January 2015 to the search date, using two complementary strategies: one addressing cognitive, functional and neurodegenerative outcomes after TBI, and one addressing biomarker and neuroimaging evidence with longitudinal and prognostic terms. Diagnostic and research criteria, neuropathological and mechanistic references, comparator biomarker studies, and treatment trials were identified through targeted retrieval and reference checking. Exhaustive title and abstract screening, dual-reviewer study selection, formal risk-of-bias assessment, and quantitative synthesis were not undertaken. Results: Four patterns of cognitive change after TBI are proposed as unvalidated longitudinal clinical heuristics rather than validated diagnostic categories, and no prevalence is estimated for any of them. Delayed progressive deterioration following an initial plateau presents the greatest diagnostic difficulty. Blood biomarkers can support evaluation for coexisting biological AD, but neurofilament light and glial fibrillary acidic protein kinetics vary with injury severity and sampling window, and no validated biomarker profile identifies injury-driven neurodegeneration in an individual patient. Tau-related pathology, impaired protein clearance, and chronic neuroinflammatory activity are plausible contributors not shown to form a unified causal cascade. Conclusion: Current evidence supports structured longitudinal reassessment and evaluation of competing explanations rather than etiological classification by biomarker pattern. A proposed assessment pathway, and a framework for stating what can and cannot be concluded in an individual patient, are offered as testable structures, including for medicolegal settings in which causal attribution is requested.
- Open Access
- 1 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357374
Observation versus coiling for unruptured intracranial aneurysms in octogenarians: A decision-analytic modeling study
Management of unruptured intracranial aneurysms in patients aged 80 years and older remains uncertain because treatment morbidity, rupture risk, post-rupture outcome, and competing mortality interact. We constructed a competing-risk Markov decision model comparing observation with endovascular coiling in Korean patients at index ages 80, 85, and 90 years; microsurgical clipping and stent-assisted coiling or flow diversion served as additional scenarios. The primary outcome was the undiscounted lifetime cumulative incidence of aneurysm- or treatment-attributable events—treatment morbidity, treatment death, rupture death, or rupture poor outcome—counted as a first-event composite in which all four components carry equal weight regardless of severity, duration, or reversibility. Periprocedural coiling morbidity and mortality were anchored to a U.S. National Inpatient Sample analysis from 2001–2008, and residual post-treatment rupture risk was fixed at 10% of the natural-history rate. Under this original endpoint, median differences favored observation in every age-90 panel and in all male panels at age ≥ 85, and favored coiling in selected age-80 panels and selected age-85 female panels; the probability that coiling was favored ranged from 0.000 to 0.984. A 24-panel, 3%-discounted severity-weighted quality-adjusted analysis was added, together with structural sensitivities for treatment-morbidity recovery, residual rupture risk, and coiling morbidity. Across 30 endpoint-direction comparisons, with each Ma panel mapped to its two legacy marginals, 21 were concordant; all nine discordant comparisons shifted from observation toward coiling, and eight had 95% quality-adjusted uncertainty intervals spanning zero. Median-direction changes under the executed structural sensitivities were confined to modified Rankin Scale-based panels with reference quality-adjusted differences near zero and uncertainty intervals spanning zero. Modeled treatment preference was therefore conditional on endpoint definition and key structural assumptions, including historical treatment-risk estimates and uncalibrated residual post-treatment rupture risk; these model outputs do not establish treatment recommendations for individual patients.
- 1 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357374
Open AccessObservation versus coiling for unruptured intracranial aneurysms in octogenarians: A decision-analytic modeling study
Management of unruptured intracranial aneurysms in patients aged 80 years and older remains uncertain because treatment morbidity, rupture risk, post-rupture outcome, and competing mortality interact. We constructed a competing-risk Markov decision model comparing observation with endovascular coiling in Korean patients at index ages 80, 85, and 90 years; microsurgical clipping and stent-assisted coiling or flow diversion served as additional scenarios. The primary outcome was the undiscounted lifetime cumulative incidence of aneurysm- or treatment-attributable events—treatment morbidity, treatment death, rupture death, or rupture poor outcome—counted as a first-event composite in which all four components carry equal weight regardless of severity, duration, or reversibility. Periprocedural coiling morbidity and mortality were anchored to a U.S. National Inpatient Sample analysis from 2001–2008, and residual post-treatment rupture risk was fixed at 10% of the natural-history rate. Under this original endpoint, median differences favored observation in every age-90 panel and in all male panels at age ≥ 85, and favored coiling in selected age-80 panels and selected age-85 female panels; the probability that coiling was favored ranged from 0.000 to 0.984. A 24-panel, 3%-discounted severity-weighted quality-adjusted analysis was added, together with structural sensitivities for treatment-morbidity recovery, residual rupture risk, and coiling morbidity. Across 30 endpoint-direction comparisons, with each Ma panel mapped to its two legacy marginals, 21 were concordant; all nine discordant comparisons shifted from observation toward coiling, and eight had 95% quality-adjusted uncertainty intervals spanning zero. Median-direction changes under the executed structural sensitivities were confined to modified Rankin Scale-based panels with reference quality-adjusted differences near zero and uncertainty intervals spanning zero. Modeled treatment preference was therefore conditional on endpoint definition and key structural assumptions, including historical treatment-risk estimates and uncalibrated residual post-treatment rupture risk; these model outputs do not establish treatment recommendations for individual patients.
- Open Access
- 9 July 2026
- Published by Elsevier in Brain Disorders
- Vol. 23
Cognitive Dysfunction in Adult Moyamoya Disease: Frontal Hemodynamics, Microstructural Vulnerability, and Surgical Considerations, With Emphasis on Non-Stroke Presentations
- 9 July 2026
- Published by Elsevier in Brain Disorders
- Vol. 23
Open AccessCognitive Dysfunction in Adult Moyamoya Disease: Frontal Hemodynamics, Microstructural Vulnerability, and Surgical Considerations, With Emphasis on Non-Stroke Presentations
- Open Access
- 8 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (10) , 3292
The Efficiency of FLAIR Images for Hemodynamic Change After STA-MCA Bypass with Moyamoya Disease and Symptomatic Steno-Occlusive Disorder
Background: Hyperintense vessels (HVs) visualized on FLAIR MRI are believed to reflect sluggish antegrade or retrograde flow in leptomeningeal collaterals that develop in response to major intracranial artery stenosis or occlusion. HV is frequently observed in conditions such as Moyamoya disease and symptomatic ICA/MCA steno-occlusion. However, the relationship between HV and cerebral hemodynamics—and the effect of STA-MCA bypass on HV—remains inadequately characterized. This study aimed to investigate the relationship between HV on FLAIR and cerebral vascular hemodynamic status, as measured by SPECT, in patients with Moyamoya disease and symptomatic ICA/MCA occlusion. The secondary goal was to assess the impact of recanalization through STA-MCA bypass surgery on the presence of HV. Methods: We retrospectively analyzed 49 patients with symptomatic ICA or MCA steno-occlusion who underwent STA-MCA bypass between 2015 and 2020. Pre- and postoperative FLAIR MRIs were evaluated, and HV presence was graded as negative (0), minimal (1), or positive (2). SPECT was utilized to assess cerebrovascular reserve (CVR) in regions exhibiting various HV intensities. Follow-up FLAIR imaging was performed 3–14 months postoperatively to correlate HV changes with hemodynamic improvements observed via SPECT. Result: HV was present in 74% (36/49) of affected hemispheres. Regions exhibiting minimal or positive HV demonstrated a significantly lower CVR compared to HV-negative areas, indicating compromised perfusion. Following bypass surgery, HV was reduced or resolved in 65% (32/49) of patients, and this regression corresponded with improved CVR as confirmed by both SPECT and perfusion MRI. Conclusions: HV presence on FLAIR imaging is associated with impaired cerebrovascular hemodynamics in patients with Moyamoya disease or symptomatic large-vessel steno-occlusion. HV-positive territories exhibit reduced CVR, while surgical revascularization via STA-MCA bypass leads to hemodynamic improvement and concurrent HV reduction. These findings support HV as a potential surrogate marker for treatment response.
- 8 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (10) , 3292
Open AccessThe Efficiency of FLAIR Images for Hemodynamic Change After STA-MCA Bypass with Moyamoya Disease and Symptomatic Steno-Occlusive Disorder
Background: Hyperintense vessels (HVs) visualized on FLAIR MRI are believed to reflect sluggish antegrade or retrograde flow in leptomeningeal collaterals that develop in response to major intracranial artery stenosis or occlusion. HV is frequently observed in conditions such as Moyamoya disease and symptomatic ICA/MCA steno-occlusion. However, the relationship between HV and cerebral hemodynamics—and the effect of STA-MCA bypass on HV—remains inadequately characterized. This study aimed to investigate the relationship between HV on FLAIR and cerebral vascular hemodynamic status, as measured by SPECT, in patients with Moyamoya disease and symptomatic ICA/MCA occlusion. The secondary goal was to assess the impact of recanalization through STA-MCA bypass surgery on the presence of HV. Methods: We retrospectively analyzed 49 patients with symptomatic ICA or MCA steno-occlusion who underwent STA-MCA bypass between 2015 and 2020. Pre- and postoperative FLAIR MRIs were evaluated, and HV presence was graded as negative (0), minimal (1), or positive (2). SPECT was utilized to assess cerebrovascular reserve (CVR) in regions exhibiting various HV intensities. Follow-up FLAIR imaging was performed 3–14 months postoperatively to correlate HV changes with hemodynamic improvements observed via SPECT. Result: HV was present in 74% (36/49) of affected hemispheres. Regions exhibiting minimal or positive HV demonstrated a significantly lower CVR compared to HV-negative areas, indicating compromised perfusion. Following bypass surgery, HV was reduced or resolved in 65% (32/49) of patients, and this regression corresponded with improved CVR as confirmed by both SPECT and perfusion MRI. Conclusions: HV presence on FLAIR imaging is associated with impaired cerebrovascular hemodynamics in patients with Moyamoya disease or symptomatic large-vessel steno-occlusion. HV-positive territories exhibit reduced CVR, while surgical revascularization via STA-MCA bypass leads to hemodynamic improvement and concurrent HV reduction. These findings support HV as a potential surrogate marker for treatment response.
- Open Access
- 16 April 2025
- Published by MDPI AG in Preprints.org
The Efficiency of FLAIR Images for Hemodynamic Change After STA-MCA Bypass with Moyamoya Disease and Symptomatic Steno-Occlusive Disorder
Purpose: Hyperintense vessels (HV) observed on FLAIR MRI are thought to represent slow antegrade or retrograde flow in leptomeningeal vessels, which develop as collat-eral pathways in response to major intracranial artery stenosis or occlusion. HV is commonly seen in conditions like Moyamoya disease and symptomatic ICA/MCA steno-occlusion. The correlation between HV and cerebral hemodynamics, as well as the effect of STA-MCA bypass surgery on HV, remains poorly understood. This study aimed to investigate the relationship between HV on FLAIR and cerebral vascular he-modynamic status, as measured by SPECT, in patients with Moyamoya disease and symptomatic ICA/MCA occlusion. The secondary goal was to assess the impact of re-canalization through STA-MCA bypass surgery on the presence of HV. Methods: For-ty-nine patients with symptomatic ICA and MCA steno-occlusion, who underwent STA-MCA bypass surgery between 2015 and 2020, were retrospectively enrolled. Pre- and postoperative FLAIR MRI images were reviewed, and the presence of HV was classified as Negative (0), Minimal (1), or Positive (2). SPECT was used to measure cerebrovascular reserve (CVR) in regions with differing HV intensity. Follow-up FLAIR imaging was performed 3 to 14 months after surgery to evaluate changes in HV and correlate these with hemodynamic improvements assessed by SPECT. Result: HV was observed in 74% (36/49) of the affected hemispheres. SPECT revealed that regions with minimal or positive HV had significantly lower CVR compared to regions with no HV, indicating poorer hemodynamic status. After STA-MCA bypass surgery, HV de-creased or disappeared in 65% (32/49) of patients. Postoperative changes in HV corre-lated with improved CVR and perfusion, as observed in both SPECT and perfusion MRI. Conclusions: The presence of HV is associated with impaired cerebral hemody-namics in patients with Moyamoya disease or severe ICA/MCA steno-occlusion. HV-positive regions exhibit lower cerebrovascular reserve compared to HV-negative regions. STA-MCA bypass surgery improves hemodynamics, and the reduction or dis-appearance of HV can serve as a marker of vascular improvement following revascu-larization.
- 16 April 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Efficiency of FLAIR Images for Hemodynamic Change After STA-MCA Bypass with Moyamoya Disease and Symptomatic Steno-Occlusive Disorder
Purpose: Hyperintense vessels (HV) observed on FLAIR MRI are thought to represent slow antegrade or retrograde flow in leptomeningeal vessels, which develop as collat-eral pathways in response to major intracranial artery stenosis or occlusion. HV is commonly seen in conditions like Moyamoya disease and symptomatic ICA/MCA steno-occlusion. The correlation between HV and cerebral hemodynamics, as well as the effect of STA-MCA bypass surgery on HV, remains poorly understood. This study aimed to investigate the relationship between HV on FLAIR and cerebral vascular he-modynamic status, as measured by SPECT, in patients with Moyamoya disease and symptomatic ICA/MCA occlusion. The secondary goal was to assess the impact of re-canalization through STA-MCA bypass surgery on the presence of HV. Methods: For-ty-nine patients with symptomatic ICA and MCA steno-occlusion, who underwent STA-MCA bypass surgery between 2015 and 2020, were retrospectively enrolled. Pre- and postoperative FLAIR MRI images were reviewed, and the presence of HV was classified as Negative (0), Minimal (1), or Positive (2). SPECT was used to measure cerebrovascular reserve (CVR) in regions with differing HV intensity. Follow-up FLAIR imaging was performed 3 to 14 months after surgery to evaluate changes in HV and correlate these with hemodynamic improvements assessed by SPECT. Result: HV was observed in 74% (36/49) of the affected hemispheres. SPECT revealed that regions with minimal or positive HV had significantly lower CVR compared to regions with no HV, indicating poorer hemodynamic status. After STA-MCA bypass surgery, HV de-creased or disappeared in 65% (32/49) of patients. Postoperative changes in HV corre-lated with improved CVR and perfusion, as observed in both SPECT and perfusion MRI. Conclusions: The presence of HV is associated with impaired cerebral hemody-namics in patients with Moyamoya disease or severe ICA/MCA steno-occlusion. HV-positive regions exhibit lower cerebrovascular reserve compared to HV-negative regions. STA-MCA bypass surgery improves hemodynamics, and the reduction or dis-appearance of HV can serve as a marker of vascular improvement following revascu-larization.
- Open Access
- 3 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4460
Long-Term Outcomes after Multimodal Treatment for Clival Chordoma: Efficacy of the Endonasal Transclival Approach with Early Adjuvant Radiation Therapy
This study investigates the long-term outcomes of clival chordoma patients treated with the endonasal transclival approach (ETCA) and early adjuvant radiation therapy. A retrospective review of 17 patients (2002–2013) showed a 10-year progression-free survival (PFS) rate of 67.4%, with the ETCA group showing fewer progressions and cranial neuropathies than those treated with combined approaches. The ETCA, a minimally invasive technique, provided a similar extent of resection compared to conventional skull-base approaches and enabled safe delivery of high-dose adjuvant radiotherapy. The findings suggest that ETCA is an effective treatment for centrally located clival chordomas.
- 3 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4460
Open AccessLong-Term Outcomes after Multimodal Treatment for Clival Chordoma: Efficacy of the Endonasal Transclival Approach with Early Adjuvant Radiation Therapy
This study investigates the long-term outcomes of clival chordoma patients treated with the endonasal transclival approach (ETCA) and early adjuvant radiation therapy. A retrospective review of 17 patients (2002–2013) showed a 10-year progression-free survival (PFS) rate of 67.4%, with the ETCA group showing fewer progressions and cranial neuropathies than those treated with combined approaches. The ETCA, a minimally invasive technique, provided a similar extent of resection compared to conventional skull-base approaches and enabled safe delivery of high-dose adjuvant radiotherapy. The findings suggest that ETCA is an effective treatment for centrally located clival chordomas.
- Open Access
- 1 March 2022
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 42 (2) , 196-202
Diagnosis of Balamuthia mandrillaris Encephalitis by Thymine–Adenine Cloning Using Universal Eukaryotic Primers
Ju Yeong Kim, M.D., Ph.D., Myung-Hee Yi, Ph.D., Myungjun Kim, B.S., Joon-Sup Yeom, M.D., D.T.M.&H., Ph.D., Hyun Dong Yoo, M.D., Seong Min Kim, M.D., Ph.D., and Tai-Soon Yong, M.D., Ph.D.. Ann Lab Med 2022;42:196-202. https://doi.org/10.3343/alm.2022.42.2.196
- 1 March 2022
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 42 (2) , 196-202
Open AccessDiagnosis of Balamuthia mandrillaris Encephalitis by Thymine–Adenine Cloning Using Universal Eukaryotic Primers
Ju Yeong Kim, M.D., Ph.D., Myung-Hee Yi, Ph.D., Myungjun Kim, B.S., Joon-Sup Yeom, M.D., D.T.M.&H., Ph.D., Hyun Dong Yoo, M.D., Seong Min Kim, M.D., Ph.D., and Tai-Soon Yong, M.D., Ph.D.. Ann Lab Med 2022;42:196-202. https://doi.org/10.3343/alm.2022.42.2.196